background
cerebr
malaria
cm
sever
malari
anemia
sma
seriou
lifethreaten
clinic
syndrom
plasmodium
falciparum
infect
childhood
therefor
import
understand
patholog
underli
develop
cm
sma
oppos
uncompl
malaria
um
differ
host
respons
infect
like
reflect
plasma
proteomepattern
associ
clinic
statu
therefor
provid
indic
pathogenesi
syndrom
method
find
plasma
comprehens
clinic
data
discoveri
valid
cohort
obtain
part
prospect
casecontrol
studi
sever
childhood
malaria
main
tertiari
hospit
citi
ibadan
urban
dens
popul
holoendem
malaria
area
nigeria
total
children
particip
studi
plasma
subject
highthroughput
proteom
profil
statist
patternrecognit
method
use
find
proteomepattern
defin
diseas
group
plasma
proteomepattern
accur
distinguish
children
cm
sma
um
healthi
sever
ill
malarianeg
children
report
accur
definit
major
childhood
malaria
syndrom
achiev
use
plasma
proteomepattern
proteom
data
exploit
understand
pathogenesi
differ
childhood
sever
malaria
syndrom
human
malaria
caus
plasmodium
falciparum
estim
annual
global
diseas
burden
million
clinic
episod
lead
one
million
death
eightyf
per
cent
case
mortal
occur
subsaharan
africa
mostli
amongst
children
recent
report
point
reduct
malaria
case
part
africa
howev
nigeria
popul
countri
africa
account
quarter
global
case
third
malariaattribut
childhood
death
cerebr
malaria
cm
sever
malari
anemia
sma
major
sever
diseas
syndrom
african
children
high
level
mortal
underf
age
group
current
case
definit
sever
malaria
combin
p
falciparum
blood
stage
parasitemia
coma
sever
anemia
respiratori
distress
well
document
signific
overlap
across
syndrom
despit
fact
case
definit
sensit
use
clinic
diagnosi
pathogenesi
sever
diseas
well
understood
one
disadvantag
clinic
definit
lack
specif
requir
carri
studi
aim
understand
pathogenesi
clinic
differ
form
childhood
malaria
previou
studi
attempt
defin
malaria
syndrom
studi
plasma
correl
sever
use
reductionist
approach
variabl
success
small
sampl
size
lack
valid
cohort
focu
small
select
host
plasma
protein
limit
studi
overcom
limit
use
system
approach
defin
plasma
proteom
profil
malaria
infect
identifi
distinct
pattern
characterist
differ
diseas
state
contrari
proteom
approach
highthroughput
plasma
proteom
profil
enabl
simultan
analysi
larg
number
sampl
therefor
plasma
proteom
profil
allow
use
statist
patternrecognit
method
discov
valid
proteomepattern
discrimin
diseas
state
hypothes
plasma
proteom
malaria
infect
reflect
molecul
modul
sever
statu
establish
present
studi
show
distinct
plasma
proteomepattern
distinguish
differ
sever
present
p
falciparum
childhood
malaria
uncompl
case
also
well
unwel
children
without
malaria
parent
guardian
studi
particip
gave
inform
written
consent
research
approv
joint
ethic
committe
colleg
medicin
univers
ibadan
univers
colleg
hospit
ibadan
studi
particip
recruit
auspic
childhood
malaria
research
group
cmrg
tertiari
hospit
univers
colleg
hospit
uch
citi
ibadan
nigeria
west
subsaharan
africa
ibadan
dens
popul
urban
set
popul
million
inhabit
ibadan
lengthi
month
raini
season
march
octob
malaria
transmiss
sever
diseas
present
year
round
holoendem
studi
site
locat
uch
ibadan
depart
paediatr
screen
children
attend
hospit
ill
well
malaria
parasit
per
year
studi
report
sma
cm
admiss
parasit
children
five
year
age
particip
studi
recruit
part
larger
prospect
casecontrol
studi
childhood
sever
malaria
current
ongo
auspic
cmrg
casecontrol
studi
divid
discoveri
cohort
consist
patient
recruit
valid
cohort
made
recruit
period
malaria
parasit
detect
count
microscopi
follow
giemsa
stain
thick
thin
blood
film
children
sever
malaria
recruit
admiss
otunba
tunwas
children
emerg
ward
otchew
children
uncompl
malaria
recruit
part
daili
routin
malaria
parasit
screen
children
outpati
clinic
chop
malarianeg
ill
children
recruit
either
admiss
otchew
depart
paediatr
inpati
ward
malarianeg
healthi
commun
control
children
recruit
local
vaccin
clinic
well
school
visit
across
sever
ibadan
district
recruit
children
age
month
year
use
five
particip
definit
malariaposit
children
case
uncompl
malaria
um
sever
malari
anemia
sma
cerebr
malaria
cm
malarianeg
children
control
diseas
control
dc
commun
control
cc
follow
criteria
sever
p
falciparum
malaria
cerebr
malaria
case
defin
children
unrous
coma
least
one
hour
presenc
asexu
p
falciparum
parasitemia
normal
cerebrospin
fluid
blantyr
coma
score
less
use
assess
coma
statu
children
hypoglycemia
exclud
studi
ad
tabl
characterist
discoveri
valid
studi
group
strict
clinic
laboratori
definit
cm
studi
patient
recov
conscious
effect
antimalari
therapi
exclud
studi
cm
patient
die
overal
mortal
rate
cm
order
sever
malari
anemia
case
defin
consciou
children
pack
cell
volum
pcv
less
presenc
p
falciparum
parasitemia
exclud
studi
sma
patient
die
overal
mortal
rate
sma
less
uncompl
malaria
case
defin
febril
children
p
falciparum
parasitemia
requir
hospit
admiss
studi
design
discov
valid
plasma
proteom
chang
dichotom
case
includ
children
cm
um
pcv
greater
tabl
exclud
studi
blood
cultur
posit
case
although
carri
blood
cultur
sever
malaria
patient
case
recruit
studi
septicemia
suspect
success
treat
antimalari
alon
dc
group
consist
malarianeg
children
infecti
diseas
mening
otiti
media
diarrhea
upper
respiratori
tract
infect
also
includ
mild
moder
anem
children
children
admit
surgeri
particip
clinic
data
collect
use
malariatailor
questionnair
design
cmrg
ml
blood
sampl
obtain
particip
edta
blood
collect
tube
subsequ
plasma
separ
blood
sampl
kept
ice
transfer
central
malaria
laboratori
plasma
studi
harvest
centrifug
g
pack
cell
volum
pcv
measur
use
microhaematocrit
method
briefli
blood
obtain
capillari
tube
tube
centrifug
g
minut
percentag
cell
volum
compar
whole
tube
volum
calcul
ie
pcv
mean
standard
deviat
sd
minimum
maximum
pcv
clinic
group
tabul
tabl
discoveri
valid
cohort
data
compar
use
oneway
multipl
anova
test
malaria
parasit
detect
count
microscopi
follow
giemsa
stain
thick
thin
blood
film
malaria
parasit
mp
densiti
calcul
follow
mp
tabl
microscop
criterion
declar
particip
free
malaria
absenc
parasit
highpow
field
one
thick
blood
film
randomli
select
independ
review
local
experienc
microscopist
part
research
team
crude
plasma
profil
use
surfac
enhanc
laser
desorptionionizationtim
flight
selditof
mass
spectrometri
plasma
sampl
underw
two
freezethaw
cycl
prior
analysi
plasma
sampl
code
blind
random
applic
onto
follow
solidphas
fraction
surfac
proteinchiph
array
biorad
weakcat
exchang
stronganion
exchang
revers
phase
previous
describ
liquid
handl
step
autom
use
biomek
laboratori
autom
workstat
beckman
coulter
well
bioprocessorh
biorad
proteinchiph
well
bioprocessorh
includ
qualiti
control
plasma
standard
deriv
singl
healthi
individu
place
random
mass
spectra
gener
system
biorad
proteinchiph
mass
spectromet
spectral
peak
correspond
masscharg
mz
cluster
detect
cluster
use
proteinchiph
datamanag
client
softwar
biorad
mass
spectromet
calibr
perform
use
peptid
protein
calibr
biorad
reproduc
determin
measur
interproteinchiph
coeffici
variat
cv
qualiti
control
spectra
base
peak
spectrum
intens
overal
interchip
cv
qualiti
control
sampl
consist
similar
studi
liquidphas
anionexchang
fraction
plasma
sampl
carri
use
proteinchiph
fraction
kit
biorad
accord
manufactur
instruct
biomek
laboratori
autom
workstat
six
fraction
obtain
sampl
elut
ph
ph
ph
ph
ph
organ
phase
select
subset
relev
mass
cluster
discoveri
cohort
group
use
weight
kernelbas
iter
estim
relev
algorithm
wkiera
combin
stochasticsearch
estim
distribut
algorithm
kernel
patternrecognit
method
use
discov
relev
subset
mass
cluster
build
discriminatori
predict
model
adopt
supervis
learn
approach
deriv
classif
rule
use
support
vector
machin
svm
method
briefli
use
cross
valid
select
paramet
svm
final
model
paramet
select
gave
overal
highest
accuraci
across
whole
cross
valid
obtain
robust
accuraci
estim
classifi
discoveri
data
took
random
resampl
data
use
train
test
select
final
classifi
one
produc
highest
accuraci
test
valid
cohort
data
result
express
sensit
specif
accuraci
proport
correct
classif
plot
receiv
oper
characterist
roc
space
plot
multivari
statist
test
includ
test
age
sex
ascertain
signific
pattern
chang
proteom
depend
variabl
popul
studi
visual
covari
within
mass
spectral
profil
use
princip
compon
analysi
pca
pca
encapsul
covari
within
set
variabl
extract
rank
set
independ
factor
princip
compon
first
compon
encompass
high
proport
inform
content
multivari
dataset
plot
patient
respect
first
compon
space
colorcod
accord
patient
group
total
children
particip
studi
part
discoveri
valid
casecontrol
cohort
discoveri
cohort
compris
malariaposit
children
either
cerebr
malaria
cm
sever
malari
anemia
sma
uncompl
malaria
um
malarianeg
children
either
diseas
control
dc
commun
control
cc
tabl
valid
cohort
prospect
recruit
discoveri
cohort
compris
malariaposit
children
either
cm
sma
um
malarianeg
dc
cc
children
tabl
pcv
malaria
parasit
mp
densiti
present
tabl
consist
recruit
criteria
discoveri
valid
sma
group
pcv
tabl
mild
anemia
across
cm
um
dc
group
cohort
wherea
cc
normal
mean
hematocrit
tabl
parasit
densiti
across
infect
group
similar
tabl
compar
proteomepattern
studi
group
fraction
plasma
sampl
three
differ
chromatographi
procedur
solidphas
surfac
weakcation
stronganion
ionexchang
reversephas
follow
timeofflight
mass
spectrometri
result
mass
spectra
surfac
contain
seri
masscharg
ratio
mz
peak
cluster
repres
protein
particular
mass
set
protein
present
absent
differ
level
sampl
defin
proteomepattern
may
discrimin
two
studi
group
discov
pattern
appli
statist
pattern
recognit
algorithm
profil
select
number
discrimin
protein
pairwis
group
comparison
shown
figur
number
parenthes
data
built
predict
model
select
proteomepattern
studi
group
comparison
use
nonparametr
supervis
learn
statist
framework
discriminatori
accuraci
predict
model
discoveri
cohort
group
shown
figur
determin
differ
malariaposit
children
healthi
malarianeg
children
compar
individu
plasma
proteom
cm
sma
um
group
cc
group
overal
protein
compos
discriminatori
pattern
accuraci
across
three
comparison
figur
blue
bar
twentysix
protein
discrimin
healthi
ill
hospit
admit
malarianeg
children
cc
vs
dc
similar
accuraci
figur
green
bar
examin
protein
specif
malaria
infect
compar
malariaposit
group
cm
sma
um
dc
group
obtain
discrimin
accuraci
figur
orang
bar
final
assess
differ
defin
malaria
syndrom
compar
malariaposit
group
figur
yellow
bar
comparison
cm
sma
two
major
sever
syndrom
accuraci
protein
higher
accuraci
observ
sampl
either
cm
sma
group
compar
um
children
use
protein
respect
valid
accuraci
discrimin
discov
plasma
proteomepattern
test
predict
model
valid
cohort
group
figur
best
predict
model
group
comparison
discoveri
cohort
ask
predict
group
class
valid
cohort
found
predict
model
obtain
use
discoveri
cohort
similar
accuraci
discrimin
differ
group
comparison
valid
cohort
figur
compar
sensit
specif
predict
model
discoveri
valid
cohort
group
roc
space
found
similar
figur
use
princip
compon
analysi
pca
select
protein
visual
separ
patient
group
cc
group
cluster
tightli
togeth
figur
green
sphere
individu
malariaposit
group
show
good
separ
malarianeg
cc
group
figur
indic
regardless
diseas
sever
signific
differ
proteom
group
heterogen
dc
group
dispers
cluster
pattern
littl
overlap
cc
group
figur
dc
group
despit
distinct
show
differ
degre
overlap
malariaposit
group
figur
comparison
cm
vs
dc
patient
group
show
greatest
level
cluster
dispers
figur
indic
greater
covari
protein
defin
group
compar
malariaposit
patient
group
among
figur
cm
sma
group
show
overlap
cluster
interfac
clearer
segreg
peripheri
comparison
sever
form
cm
sma
um
observ
sever
patient
group
compact
center
cluster
surround
dispers
cluster
um
patient
group
simplifi
complex
plasma
proteom
highthroughput
liquidphas
anionexchang
fraction
follow
solidphas
weakcat
exchang
fraction
prior
protein
mass
determin
spectromet
subset
sampl
assess
discriminatori
accuraci
relev
protein
obtain
six
anionexchang
fraction
figur
data
reduct
complex
fraction
plasma
sampl
result
larger
subset
protein
improv
discrimin
malaria
syndrom
set
protein
distinguish
sma
cm
group
figur
bracket
slightli
outperform
proteomepattern
nonfraction
plasma
set
protein
differenti
cm
um
group
accuraci
rang
figur
bracket
distinguish
sma
um
compar
accuraci
figur
bracket
carri
overal
analysi
plasma
proteom
pattern
overlap
compar
discov
set
protein
discrimin
um
cm
sma
malariaposit
dc
malarianeg
ill
children
malarianeg
well
children
cc
figur
show
plasma
fraction
contain
set
protein
clearli
defin
malariaposit
malarianeg
ill
children
malarianeg
well
children
commun
furthermor
also
show
set
protein
discrimin
sma
cm
um
littl
overlap
across
six
plasma
fraction
figur
present
studi
carri
larg
casecontrol
studi
sever
childhood
malaria
use
discoveri
cohort
defin
discriminatori
plasma
proteomepattern
second
cohort
valid
find
main
tertiari
hospit
citi
ibadan
nigeria
show
proteomepattern
crude
prefraction
plasma
sampl
accur
defin
childhood
malaria
syndrom
discoveri
cohort
confirm
find
use
prospect
collect
valid
cohort
malaria
infect
introduc
distinguish
chang
plasma
proteom
children
seen
strike
differ
malarianeg
cc
malariaposit
children
group
plasma
proteom
differ
specif
malaria
diseas
process
surrog
marker
acut
ill
abl
accur
distinguish
malarianeg
ill
children
malariaposit
group
independ
diseas
sever
also
discov
plasma
proteom
differ
specif
childhood
malaria
syndrom
assess
present
studi
find
provid
start
point
refin
current
definit
syndrom
lack
necessari
specif
studi
sever
malaria
pathogenesi
show
assess
plasma
proteom
major
malaria
syndrom
provid
unbias
discoveri
combin
protein
could
use
deepen
understand
pathogenesi
childhood
malaria
support
find
discrimin
children
uncompl
malaria
sever
malari
anemia
cerebr
malaria
discoveri
valid
cohort
proteomepattern
encapsul
chang
differenti
uncompl
malaria
sever
case
overal
accuraci
discrimin
cm
sma
lower
comparison
syndrom
um
group
degre
overlap
cm
sma
goe
beyond
expect
strict
applic
case
definit
use
studi
nevertheless
plasma
proteomepattern
discrimin
accuraci
sever
group
suggest
beyond
common
underli
mechan
acut
inflamm
signific
differ
pathogenesi
sever
syndrom
studi
larg
cohort
allow
us
statist
valid
patternbas
proteom
definit
major
childhood
malaria
syndrom
although
mass
spectrometri
platform
use
studi
provid
direct
molecular
identif
chromatograph
chemistri
use
masstocharg
mz
ratio
exploit
guid
identif
set
protein
relev
discrimin
syndrom
plasma
proteom
profil
use
defin
varieti
diseas
state
grow
recognit
advantag
use
omicsbas
method
achiev
suffici
level
accuraci
studi
show
complex
plasma
protein
pattern
necessari
discrimin
differ
malaria
syndrom
underlin
advantag
use
unbias
highthroughput
pattern
recognit
base
method
mani
infecti
diseas
clinic
import
distinct
made
differ
manifest
associ
underli
pathogen
malaria
clinic
syndrom
clear
case
point
pathogenesi
malaria
due
erythrocyt
cycl
occur
cardiovascular
system
plausibl
proteom
chang
organ
brain
spleen
kidney
bone
marrow
reflect
plasma
proteom
studi
confirm
proteom
chang
characterist
clinic
malari
syndrom
differ
level
accuraci
furthermor
host
modul
pathogen
like
gener
chang
pattern
protein
express
associ
progress
sever
malaria
syndrom
current
studi
design
address
chang
lack
specif
childhood
malaria
definit
limit
progress
understand
patholog
major
sever
syndrom
best
knowledg
studi
first
show
panel
protein
defin
proteomepattern
dissect
clinic
malaria
syndrom
identif
protein
compris
proteomepattern
provid
hint
underli
pathogenesi
syndrom
furthermor
proteomepattern
provid
refer
point
facilit
identif
complex
overlap
sever
childhood
malaria
syndrom
data
solidphas
fraction
data
xl
data
liquidphas
fraction
data
xl
